Brief: Immucell Says Total Prelim Product Sales Increased By About 24% To About $3.6 Mln During Q4
Jan 21 (Reuters) - ImmuCell Corp ICCC.O :
* IMMUCELL ANNOUNCES PRELIMINARY, UNAUDITED PRODUCT SALES
RESULTS
FOR THE YEAR ENDED DECEMBER 31, 2019
* IMMUCELL CORP - TOTAL PRELIM PRODUCT SALES INCREASED BY
ABOUT
$695,000, OR 24%, TO ABOUT $3.6 MILLION DURING Q4
Source text for Eikon: ID:nGNX8wXcRM
Further company coverage: ICCC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ImmuCell
See all newsBrief: Immucell Announces A 46% Increase In Product Sales In Quarter Three Of 2026, Based On Preliminary, Unaudited Sales Results
ImmuCell Q2 revenue rises on higher distributor volume, price realization
Brief: ImmuCell Corporation Q2 EPS USD 0.2
ImmuCell Q2 product sales rise 11.5% on strong US demand
ImmuCell Q1 sales, profit rise on seasonal demand; to moderate mid-year